Reduced Pms2 expression in non-neoplastic flat mucosa from patients with colon cancer correlates with reduced apoptosis competence

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 2, 2006, Pages 166-172

  Bernstein, Harris ^a   Prasad, Anil ^b   Holubec, Hana ^a   Bernstein, Carol ^a,b   Payne, Claire M ^a,b   Ramsey, Lois ^b   Dvorakova, Katerina ^a,b   Wilson, Megan ^a   Warneke, James A ^a   Garewal, Harinder ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Apoptosis; Bile acid; Colon cancer; Mismatch repair; Pms2

Indexed keywords

BIOLOGICAL MARKER; DNA; MISMATCH REPAIR PROTEIN PMS2;

ARTICLE; CANCER GROWTH; CANCER RISK; CELL NUCLEUS; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA REPLICATION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ADENOSINE TRIPHOSPHATASES; APOPTOSIS; COLONIC NEOPLASMS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; INTESTINAL MUCOSA; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745388068     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000170533.61579.b9     Document Type: Article

References (46)

1. Bernstein C, Bernstein H, Payne CM, et al. DNA repair/proapoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res. 2002;511:145-178.
2. Guerrette S, Acharya S, Fishel R. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem. 1999;274:6336-6341.
3. Kondo E, Horii A, Fukushige S. The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous atnino acid residues within hMLH3, hPMS1 and hPMS2. Nucleic Acids Res. 2001;29:1695-1702.
4. Jiricny J, Nystrom-Lahti M. Mismatch repair defects in cancer. Curr Opin Genet Dev. 2000;10:157-161.
5. Lynch HT, Smyrk T, Lynch JF. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int J Cancer. 1996;69:38-43.
6. Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet. 1995;9:48-55.
7. Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted colectomy for colon cancer. N Engl J Med. 2004;350:2050-2059.
8. Tangrea JA, Albert PS, Lanza E, et al. Polyp Prevention Study Group. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control. 2003;14:403-411.
9. Gelfand DW. Decreased risk of subsequent colonic cancer in patients undergoing polypectomy after barium enema: analysis based on data from the preendoscopic era. AJR Am J Roentgenol. 1997;169:1243-1245.
10. Bernstein H, Holubec H, Warneke JA, et al. Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients. Ann Surg Oncol. 2002;9:505-517.
11. Bernstein C, Bernstein H, Garewal H, et al. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res. 1999;59:2353-2357.
12. Narayanan L, Fritzell JA, Baker SM, et al. Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc Natl Acad Sci USA. 1997;94:3122-3127.
13. Dobrovolsky VN, McKinzie PB, Shaddock JG, et al. Pms2 deficiency results in increased mutation in the Hprt gene but not the Tk gene of Tk(+/-) transgenic mice. Mutagenesis. 2003;18:365-370.
14. Hardman RA, Afshari CA, Barrett JC. Involvement of mammalian MLH1 in the apoptotic response to peroxide-induced oxidative stress. Cancer Res. 2001;61:1392-1397.
15. Aquilina G, Bignami M. Mismatch repair in correction of replication errors and processing of DNA damage. J Cell Physiol. 2001;187:145-154.
16. Branch P, Hampson R, Karran P. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res. 1995;55:2304-2309.
17. D'Atri S, Tentori L, Lacal PM, et al. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol. 1998;54:334-341.
18. Humbert O, Fiumicino S, Aquilina G, et al. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents. Carcinogenesis. 1999;20:205-214.
19. Koi M, Umar A, Chauhan DP, et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N- nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 1994;54:4308-4312.
20. Peters AC, Young LC, Maeda T, et al. Mammalian DNA mismatch repair protects cells from UVB-induced DNA damage by facilitating apoptosis and p53 activation. DNA Repair (Amst). 2003;2:427-435.
21. Wu J, Gu L, Wang H, et al. Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis. Mol Cell Biol. 1999;19:8292-8301.
22. Sansom OJ, Bishop SM, Court H, et al. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. DNA Repair (Amst). 2003;2:1029-1039.
23. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, et al. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci USA. 2003;100:2420-2425.
24. Ling WH. Diet and colonic micronora interaction in colorectal cancer. Nutr Res. 1995;15:439-454.
25. Cheah PY. Hypotheses for the etiology of colorectal cancer: an overview. Nutr Cancer. 1990;14:5-13.
26. Allinger UG, Johansson GK, Gustafsson JA, et al. Shift from a mixed to a lactovegetarian diet: influence on acidic lipids in fecal water - a potential risk factor for colon cancer. Am J Clin Nutr. 1989;50:992-996.
27. Payne CM, Bernstein H, Bernstein C, et al. Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis. Ultrastruct Pathol. 1995;19:221-248.
28. Garewal H, Bernstein H, Bernstein C, et al. Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. Cancer Res. 1996;56:1480-1483.
29. Kulkarni MS, Cox BA, Yielding KL. Requirements for induction of DNA strand breaks by lithocholic acid. Cancer Res. 1982;42:2792-2795.
30. Kandell RL, Bernstein C. Bile salt/acid induction of DNA damage in bacterial and mammalian cells: implications for colon cancer. Nutr Cancer. 1991;16:227-238.
31. Hamada K, Umemoto A, Kajikawa A, et al. In vitro formation of DNA adducts with bile acids. Carcinogenesis. 1994;15:1911-1915.
32. Booth LA, Gilmore IT, Bilton RF. Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved? Free Radic Res. 1997;26:135-144.
33. Venturi M, Hambly RJ, Glinghammar B, et al. Genotoxic activity in human faecal water and the role of bile acids: a study using the alkaline comet assay. Carcinogenesis. 1997;18:2353-2359.
34. Payne CM, Crowley C, Washo-Stultz D, et al. The stress-response proteins poly(ADP-ribose) polymerase and NF-kappaB protect against bile salt-induced apoptosis. Cell Death Differ. 1998;5:623-636.
35. Allgayer H, Kolb M, Stuber V, et al. Modulation of base hydroxylation by bile acids and salicylates in a model of human colonic mucosal DNA: putative implications in colonic cancer. Dig Dis Sci. 1999;44:761-767.
36. Jolly AJ, Wild CP, Hardy LJ. Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis. 2004;19:319-324.
37. Bernstein H, Payne CM, Bernstein C, et al. Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate. Toxicol Lett. 1999;108:37-46.
38. Washo-Stultz D, Crowley-Weber CL, Dvorakova K, et al. Role of mitochondrial complexes I and II, reactive oxygen species and arachidonic acid metabolism in deoxycholate-induced apoptosis. Cancer Lett. 2002;177:129-144.
39. Crowley-Weber CL, Dvorakova K, Crowley C, et al. Nicotine increases oxidative stress, activates NF-κB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chemico-Biol Interactions. 2003;145:53-56.
40. Chang CL, Marra G, Chauhan DP, et al. Oxidative stress inactivates the human DNA mismatch repair system. Am J Physiol Cell Physiol. 2002;283:C148-C154.
41. Crowley-Weber CL, Payne CM, Gleason-Guzman M, et al. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis. 2002;23:2063-2080.
42. Hegde P, Qi R, Gaspard R, et al. Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res. 2001;61:7792-7797.
43. Truninger K, Menigatti M, Haider R, et al. Loss of PMS2 protein expression is not infrequent in colorectal cancer. Gastroenterology (Supplement). 2004;126:A241.
44. Jiricny J, Marra G. DNA repair defects in colon cancer. Curr Opin Genet Dev. 2003;13:61-69.
45. Muller W, Burgart LJ, Krause-Paulus R, et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - results of an international collaborative study. Fam Cancer. 2001;1:87-92.
46. Shia J, Klimstra DS, Nafa K, et al. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol. 2005;29:96-104.